Approximately 6% of adults worldwide have atherosclerosis and thrombosis of the lower
limb arteries (peripheral artery disease (PAD)) and the prevalence is rising. PAD causes leg …

Effective revascularization of the patient with peripheral artery disease is about more than
the procedure. The approach to the patient with symptom-limiting intermittent claudication or …

Background: Peripheral artery disease (PAD) affects more than 202 million people
worldwide. Several studies have shown that patients with PAD are often undertreated, and …

Diabetic foot is a clinical manifestation of diabetes with a wide range of symptoms, including
ulceration, osteomyelitis, osteoarticular destruction, and gangrene, as a consequence of …

Atherosclerosis is a multifactorial, lipoprotein-driven condition that leads to plaque formation
within the arterial tree, leading to subsequent arterial stenosis and thrombosis that accounts …

1.1. Purpose The European Society for Vascular Surgery (ESVS) has developed a series of
clinical practice guidelines for clinicians caring for patients with vascular diseases. This is …

Patients with lower limb artery stenosis or occlusion (peripheral artery disease; PAD) have
been determined to be at very high risk of both major adverse cardiovascular events, such …

BACKGROUND: Rivaroxaban plus aspirin compared with aspirin alone reduced major
cardiac and ischemic limb events after lower extremity revascularization (LER) in the …

Atherosclerosis, while initially deemed a bland proliferative process, is now recognized as a
multifactorial-lipoprotein-mediated inflammation-driven pathway. With the rising incidence of …

Background Patients with peripheral artery disease (PAD) are at risk for amputation. The aim
of this study was to assess the type of revascularization prior to and the 30-day mortality rate …